Skip to main content
Fig. 4 | Cancer Cell International

Fig. 4

From: Highly expressed RPLP2 inhibits ferroptosis to promote hepatocellular carcinoma progression and predicts poor prognosis

Fig. 4

DNA methylation level of RPLP2 and its relationship with the prognosis of HCC patients. A The promoter methylation features of RPLP2 in HCC obtained from UALCAN database (n of normal = 165, n of tumor = 165). B, C The promoter methylation level of RPLP2 was analyzed by the tumor grade (B) and the main pathological stages (C) of HCC via UALCAN database. D Correlation between RPLP2 expression and methylation level in HCC obtained from MethSurv database. E–I Kaplan–Meier survival curves showing the effect of methylation levels in the CpG sites of RPLP2 on the prognosis of HCC patients obtained form MethSurv database. ns nonsignificant (P > 0.05), ***P < 0.001, ****P < 0.0001

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us